Yenzym Antibodies LLC

General Bioscience Corporation is a biotechnology company based in Brisbane, California, USA. Specializing in cutting-edge research and development, they are dedicated to advancing the field of bioscience through innovative solutions and technologies. With a focus on biotechnology, General Bioscience Corporation is committed to driving progress in the industry through their state-of-the-art facilities and expert team of scientists. Their mission is to make a meaningful impact on the world through groundbreaking advancements in bioscience. Generated from their website's infomation

Harpoon Therapeutics, Inc is an immuno-oncology company based in South San Francisco. They utilize a proprietary technology platform that targets T cell engagement to create innovative biologics for cancer and other diseases. Specializing in the discovery and development of novel treatments, Harpoon Therapeutics is dedicated to advancing the field of immuno-oncology. Their focus on T cell engagement sets them apart in the quest to combat cancer and improve patient outcomes. Generated from their website's infomation

Walking Fish Therapeutics, Inc. is a biotech company based in South San Francisco, CA, specializing in the development of cell-based therapeutics for the treatment of serious diseases, with a focus on oncology and regenerative therapies. They have created a powerful B cell platform that harnesses the production capabilities of B cells to deliver multiple potent therapeutic proteins, offering potential applications in various fields such as autoimmune diseases, infectious diseases, deficiency diseases, and cancer treatment. Co-founded and led by Lewis Rusty Williams, an experienced entrepreneur in the biotech industry, Walking Fish Therapeutics has assembled a distinguished team of experts in cell engineering, manufacturing, and clinical research, supported by renowned scientific and strategic advisors. With their deep understanding of B cell biology and critical advances in engineering technologies, Walking Fish is at the forefront of this emerging field, aiming to revolutionize the development of B cell therapies for multiple diseases.Generated from the website